Abstract:Osteoarthritis (OA) has become one of the most prevalent and costly diseases worldwide. Previous studies have confirmed that subchondral bone abnormal remodeling caused by overactive osteoclast bone resorption was the major cause of OA. In this study, we fabricated a bisphosphonate-conjugated nano-apatite (NP-BP) system via hydrothermal method and in-situ adsorption process. The NP-BP showed sustainable and pH-responsive release behavior of bisphosphonate. The in vitro experiment revealed that NP-BP could effectively inhibit osteoclast differentiation and suppress osteoclast bone resorption through down regulating the expressions of osteoclastic related genes, including TRAP, OSCAR, NFATc1, and Cathepsin K. The in vivo study in an OA rat model indicated that the NP-BP could relieve joint pain, attenuate articular cartilage degeneration, and lower histologic OARSI score. In parallel, the micro-CT analysis, including total tissue volume (TV), subchondral bone plate thickness (SBP Th.), and trabecular pattern factor (Tb. Pf), showed that the NP-BP could efficiently inhibit subchondral bone abnormal remodeling. In addition, the immunostaining analyses and the micro-CT based angiography demonstrated that the NP-BP suppressed the expressions of Collagen X, RANKL, Osterix, and CD31 and inhibited aberrant angiogenesis. Moreover, the NP-BP inhibited the intrusion of subchondral bone into calcified cartilage. As a result, the developed pH-responsive NP-BP system, which showed high efficiency in inhibiting osteoclastic bone resorption and subchondral bone abnormal remodeling, has potential applications for early OA treatment.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to alleviate osteoarthritis (OA) by suppressing osteoclast - mediated bone resorption. Specifically, the researchers developed a pH - responsive bisphosphonate - conjugated nano - hydroxyapatite system (NP - BP), aiming to efficiently inhibit abnormal subchondral bone remodeling and thus slow down the development of osteoarthritis. ### Research Background Osteoarthritis is a common joint disease, and its main features include joint cartilage degeneration, joint pain and dysfunction. With the aging of the population, the prevalence of osteoarthritis continues to rise and has become one of the main causes of physical disability. Although joint replacement surgery can be used for the treatment of advanced osteoarthritis at present, its effect is not ideal and the service life of the prosthesis is limited. Therefore, preventing the occurrence and development of the disease, especially effective treatment in the early stage, has become a current research hotspot. ### Core of the Problem Studies have shown that abnormal remodeling of subchondral bone is caused by over - active osteoclast bone resorption, which is the main cause of osteoarthritis. Therefore, inhibiting the activity of osteoclasts and then inhibiting the abnormal remodeling of subchondral bone has become an attractive treatment strategy. ### Solution The researchers designed and prepared a pH - responsive bisphosphonate - conjugated nano - hydroxyapatite system (NP - BP). This system has the following characteristics: - **pH - responsiveness**: Under lower pH conditions (for example, the pH value in the osteoclast microenvironment is about 4.5), NP - BP can rapidly release bisphosphonates, while it releases slowly under neutral or higher pH conditions. - **Efficiently inhibiting osteoclast activity**: In vitro experiments have shown that NP - BP can effectively inhibit the differentiation and bone resorption function of osteoclasts by down - regulating the expression of osteoclast - related genes (such as TRAP, OSCAR, NFATc1 and Cathepsin K). - **Improving osteoarthritis symptoms**: In vivo experiments (using an OA rat model) showed that NP - BP can relieve joint pain, slow down joint cartilage degeneration and reduce the histological score (OARSI score). - **Inhibiting abnormal subchondral bone remodeling**: Micro - CT analysis showed that NP - BP can significantly inhibit abnormal subchondral bone remodeling, including reducing the total tissue volume (TV), increasing the subchondral bone plate thickness (SBP Th.), and reducing the trabecular pattern factor (Tb. Pf). ### Conclusion In summary, the pH - responsive NP - BP system developed in this study shows high efficiency in suppressing osteoclast - mediated bone resorption and abnormal subchondral bone remodeling, and has potential clinical application value, especially in the treatment of early - stage osteoarthritis.

Attenuating osteoarthritis by a high efficient anti-bone resorption injectable pH-responsive bisphosphonate-conjugated nano-apatite system

Prussian Blue Nanozyme Normalizes Microenvironment to Delay Osteoporosis

Novel one-pot strategy for fabrication of a pH-Responsive bone-targeted drug self-frame delivery system for treatment of osteoporosis

A Bone Targeting Nanoparticle Loaded Ogp to Restore Bone Homeostasis for Osteoporosis Therapy

Smart Nanosacrificial Layer on the Bone Surface Prevents Osteoporosis through Acid–Base Neutralization Regulated Biocascade Effects

Multifunctional polymeric nanocapsules with enhanced cartilage penetration and retention for osteoarthritis treatment

Fluffy hybrid nanoadjuvants for reversing the imbalance of osteoclastic and osteogenic niches in osteoporosis

3D Printed Calcium Phosphate Physiochemically Dual-Regulating Pro-Osteogenesis and Antiosteolysis for Enhancing Bone Tissue Regeneration

Acid Neutralization and Immune Regulation by Calcium–Aluminum-Layered Double Hydroxide for Osteoporosis Reversion

Injectable double-crosslinked bone cement with enhanced bone adhesion and improved osteoporotic pathophysiological microenvironment for osteoregeneration in osteoporosis

Understanding the Influence of Alendronate on the Morphology and Phase Transformation of Apatitic Precursor Nanocrystals.

The nanoformula of zoledronic acid and calcium carbonate targets osteoclasts and reverses osteoporosis

Biodegradable Hollow-Structured Nanozymes Modulate Phenotypic Polarization of Macrophages and Relieve Hypoxia for Treatment of Osteoarthritis

Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis

pH-Sensitive nanocarrier assisted delivery of adenosine to treat osteoporotic bone loss

A hyaluronic acid/platelet-rich plasma hydrogel containing MnO2 nanozymes efficiently alleviates osteoarthritis in vivo

High-Efficiency Treatment for Osteoarthritis Via Self-Assembled Dual-Functionalized Nanobiologics.

Smart osteoclasts targeted nanomedicine based on amorphous CaCO3 for effective osteoporosis reversal

Nanozyme-enhanced injectable hyaluronic acid-based hydrogel for the treatment of osteoarthritis

Bone-Targeted Biomimetic Nanogels Re-Establish Osteoblast/Osteoclast Balance to Treat Postmenopausal Osteoporosis

An Injectable Hydrogel Composing Anti‐inflammatory and Osteogenic Therapy towards Bone Erosions Microenvironment Remodeling in Rheumatoid Arthritis